Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas

NCT00880581 is registered in ClinicalTrials.gov with Ronald Levy as lead sponsor.

NCT NCT00880581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas
Lead sponsor
Ronald Levy
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
January 31, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, lymphoma, non-hodgkin, lymphomas: non-hodgkin, lymphomas: non-hodgkin follicular / indolent b-cell